v3.26.1
CONTINGENT CONSIDERATION AND INTANGIBLE ASSET (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Feb. 25, 2025
Mar. 31, 2026
Oct. 20, 2025
Ciro Leonardo Pierri [Member] | Maximum [Member]      
Maximum amount payable     $ 1,600
MitoCareX Bio Ltd [Member]      
Business Combination, Consideration Transferred, Equity Interest   $ 393  
Cash consideration   536  
Contingent consideration   $ 863  
MitoCareX Bio Ltd [Member] | Ciro Leonardo Pierri [Member]      
Ownership percentage 30.00%    
MitoCareX Bio Ltd [Member]      
Subsidiary, ownership percentage, parent     25.00%